Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,501 | 478 | 99.6% |
| Education | $25.45 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $620.94 | 47 | $0 (2024) |
| Amgen Inc. | $578.59 | 41 | $0 (2024) |
| Novo Nordisk Inc | $557.74 | 43 | $0 (2024) |
| PFIZER INC. | $535.67 | 51 | $0 (2024) |
| Dexcom, Inc. | $484.16 | 42 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $451.11 | 17 | $0 (2024) |
| Allergan, Inc. | $375.39 | 33 | $0 (2020) |
| Merck Sharp & Dohme LLC | $365.61 | 37 | $0 (2024) |
| ABBVIE INC. | $362.79 | 22 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $265.14 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $898.42 | 53 | Novo Nordisk Inc ($165.78) |
| 2023 | $1,379 | 86 | PFIZER INC. ($188.08) |
| 2022 | $847.83 | 66 | Dexcom, Inc. ($200.55) |
| 2021 | $514.53 | 37 | AstraZeneca Pharmaceuticals LP ($61.38) |
| 2020 | $830.28 | 59 | AstraZeneca Pharmaceuticals LP ($160.62) |
| 2019 | $674.92 | 62 | PFIZER INC. ($123.09) |
| 2018 | $633.88 | 52 | Amgen Inc. ($110.45) |
| 2017 | $747.14 | 65 | Janssen Pharmaceuticals, Inc ($153.04) |
All Payment Transactions
480 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Biological | ||||||
| 12/03/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: VACCINE | ||||||
| 11/26/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Bone Health | ||||||
| 11/25/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/21/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: Neuroscience | ||||||
| 11/05/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: ANTI-ANXIETY | ||||||
| 10/28/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $10.58 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Biological | ||||||
| 10/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.53 | General |
| 09/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Obesity | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Bone Health | ||||||
| 08/06/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $9.13 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 684 | 923 | $116,420 | $62,070 |
| 2022 | 8 | 705 | 921 | $110,046 | $59,702 |
| 2021 | 8 | 673 | 890 | $105,182 | $60,748 |
| 2020 | 4 | 496 | 655 | $65,965 | $36,535 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 272 | 411 | $49,731 | $25,140 | 50.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 161 | 161 | $32,200 | $20,594 | 64.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 182 | 257 | $21,074 | $10,881 | 51.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 20 | 20 | $3,260 | $2,560 | 78.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 15 | $2,670 | $1,456 | 54.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 11 | 33 | $5,808 | $865.28 | 14.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 13 | 13 | $1,053 | $505.12 | 48.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 12 | 13 | $624.00 | $69.96 | 11.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 262 | 363 | $43,923 | $20,844 | 47.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 141 | 141 | $28,200 | $18,445 | 65.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 222 | 335 | $27,470 | $14,667 | 53.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 15 | 15 | $4,425 | $2,516 | 56.8% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 18 | 20 | $3,480 | $2,266 | 65.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 11 | 11 | $884.00 | $529.30 | 59.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 16 | 16 | $704.00 | $337.33 | 47.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 20 | 20 | $960.00 | $97.56 | 10.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 280 | 416 | $46,354 | $25,039 | 54.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 130 | 130 | $26,000 | $17,250 | 66.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 181 | 260 | $20,022 | $11,514 | 57.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 17 | 17 | $5,015 | $2,862 | 57.1% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 22 | 23 | $3,778 | $2,639 | 69.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 15 | 16 | $2,176 | $679.04 | 31.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $1,021 | $658.20 | 64.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 17 | 17 | $816.00 | $105.92 | 13.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 243 | 350 | $31,343 | $16,972 | 54.1% |
About Dr. Scott Boyens, MD
Dr. Scott Boyens, MD is a Family Medicine healthcare provider based in Sioux Falls, South Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1700886389.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Boyens, MD has received a total of $6,526 in payments from pharmaceutical and medical device companies, with $898.42 received in 2024. These payments were reported across 480 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($6,501).
As a Medicare-enrolled provider, Boyens has provided services to 2,558 Medicare beneficiaries, totaling 3,389 services with total Medicare billing of $219,055. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Sioux Falls, SD
- Active Since 07/26/2005
- Last Updated 01/18/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1700886389
Products in Payments
- Dexcom G6 Transmitter (Medical Supply) $348.61
- FARXIGA (Drug) $285.83
- Ozempic (Drug) $284.63
- EVENITY (Biological) $274.01
- UBRELVY (Drug) $259.63
- MOUNJARO (Drug) $224.09
- VIBERZI (Drug) $203.74
- JANUVIA (Drug) $196.15
- ELIQUIS (Drug) $180.53
- Vascepa (Drug) $178.89
- Rybelsus (Drug) $176.50
- Cologuard Collection Kit (Device) $153.09
- XARELTO (Drug) $143.72
- Aimovig (Biological) $143.15
- JARDIANCE (Drug) $142.25
- VRAYLAR (Drug) $138.02
- INJECTAFER (Drug) $134.92
- INVOKANA (Drug) $121.42
- AIRSUPRA (Drug) $117.16
- EMGALITY (Drug) $116.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Sioux Falls
Dr. Elizabeth Jensen, Do, DO
Family Medicine — Payments: $23,645
Dr. Andrew Burchett, D.o, D.O
Family Medicine — Payments: $16,792
Lornell Hansen, Md, MD
Family Medicine — Payments: $11,056
Jeffry Meyer, Md, MD
Family Medicine — Payments: $8,449
William Buchner, Md, MD
Family Medicine — Payments: $5,715
Dustin Snelling, Md, MD
Family Medicine — Payments: $5,561